HUP0101507A3 - Formulation for the prevention or the treatment of diseases affecting mucosae or skin, or for pregnancy prevention, and an applicator for the delivery of topical formulation into mucosal cavities - Google Patents

Formulation for the prevention or the treatment of diseases affecting mucosae or skin, or for pregnancy prevention, and an applicator for the delivery of topical formulation into mucosal cavities

Info

Publication number
HUP0101507A3
HUP0101507A3 HU0101507A HUP0101507A HUP0101507A3 HU P0101507 A3 HUP0101507 A3 HU P0101507A3 HU 0101507 A HU0101507 A HU 0101507A HU P0101507 A HUP0101507 A HU P0101507A HU P0101507 A3 HUP0101507 A3 HU P0101507A3
Authority
HU
Hungary
Prior art keywords
prevention
formulation
mucosae
applicator
skin
Prior art date
Application number
HU0101507A
Other languages
English (en)
Original Assignee
Infectio Rech Inc Sainte Foy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA002257001A external-priority patent/CA2257001A1/en
Application filed by Infectio Rech Inc Sainte Foy filed Critical Infectio Rech Inc Sainte Foy
Publication of HUP0101507A2 publication Critical patent/HUP0101507A2/hu
Publication of HUP0101507A3 publication Critical patent/HUP0101507A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M3/00—Medical syringes, e.g. enemata; Irrigators
    • A61M3/02—Enemata; Irrigators
    • A61M3/0233—Enemata; Irrigators characterised by liquid supply means, e.g. from pressurised reservoirs
    • A61M3/0254—Enemata; Irrigators characterised by liquid supply means, e.g. from pressurised reservoirs the liquid being pumped
    • A61M3/0262—Enemata; Irrigators characterised by liquid supply means, e.g. from pressurised reservoirs the liquid being pumped manually, e.g. by squeezing a bulb
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M3/00—Medical syringes, e.g. enemata; Irrigators
    • A61M3/02—Enemata; Irrigators
    • A61M3/0279—Cannula; Nozzles; Tips; their connection means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00—Devices for applying media, e.g. remedies, on the human body
    • A61M35/003—Portable hand-held applicators having means for dispensing or spreading integral media
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/10—Trunk
    • A61M2210/1042—Alimentary tract
    • A61M2210/1067—Anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/14—Female reproductive, genital organs
    • A61M2210/1475—Vagina

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Virology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
HU0101507A 1998-04-21 1999-04-21 Formulation for the prevention or the treatment of diseases affecting mucosae or skin, or for pregnancy prevention, and an applicator for the delivery of topical formulation into mucosal cavities HUP0101507A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA2235427 1998-04-21
CA002257001A CA2257001A1 (en) 1998-12-23 1998-12-23 Method and formulations for prevention of infection of mucosae and/or skin and development of a vaginal/ano-rectal applicator for the delivery of topical formulations
PCT/CA1999/000359 WO1999053897A2 (en) 1998-04-21 1999-04-21 Topical formulation comprising poloxamers and further microbicides, and an applicator

Publications (2)

Publication Number Publication Date
HUP0101507A2 HUP0101507A2 (hu) 2002-03-28
HUP0101507A3 true HUP0101507A3 (en) 2002-10-28

Family

ID=25680156

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0101507A HUP0101507A3 (en) 1998-04-21 1999-04-21 Formulation for the prevention or the treatment of diseases affecting mucosae or skin, or for pregnancy prevention, and an applicator for the delivery of topical formulation into mucosal cavities

Country Status (22)

Country Link
US (2) US6500460B1 (hu)
EP (2) EP1769821A1 (hu)
JP (1) JP4665075B2 (hu)
KR (1) KR20010042875A (hu)
CN (2) CN100396344C (hu)
AR (1) AR018194A1 (hu)
AT (1) ATE355050T1 (hu)
AU (1) AU762461B2 (hu)
BR (1) BR9909801A (hu)
DE (1) DE69935325T2 (hu)
ES (1) ES2284250T3 (hu)
HK (1) HK1037861A1 (hu)
HU (1) HUP0101507A3 (hu)
ID (1) ID26791A (hu)
IL (1) IL139173A0 (hu)
NO (1) NO20005310L (hu)
NZ (1) NZ507609A (hu)
PL (1) PL344111A1 (hu)
RU (1) RU2224503C2 (hu)
SK (1) SK15822000A3 (hu)
TR (2) TR200003074T2 (hu)
WO (1) WO1999053897A2 (hu)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100396344C (zh) * 1998-04-21 2008-06-25 瑞克尔科感染公司 用于将液体至半固体的制剂给药至患者粘膜腔内的施用器
US6835717B2 (en) * 2000-03-08 2004-12-28 The Johns Hopkins University School Of Medicine β-cyclodextrin compositions, and use to prevent transmission of sexually transmitted diseases
US7465295B2 (en) 2000-10-20 2008-12-16 Bergeron Michel G Applicator for the delivery of topical formulations into mucosal cavities
WO2004026255A2 (en) * 2002-09-20 2004-04-01 La Jolla Biosciences Compositions and methods for preventing infection
CA2518763A1 (en) * 2003-03-14 2004-09-23 Epistem Limited Treatment and/or prevention of non-viral epithelial damage
DE10328942A1 (de) * 2003-06-27 2005-01-27 Lts Lohmann Therapie-Systeme Ag Transmukosale Darreichungsformen mit verminderter Schleimhautirritation
CN1311873C (zh) * 2004-06-30 2007-04-25 上海复康医药科技发展有限公司 一种温度敏感的阴道用原位凝胶制剂
US20060127459A1 (en) * 2004-12-15 2006-06-15 Lei Huang Urogenital infection inhibition
US7745158B2 (en) * 2005-12-14 2010-06-29 Kimberly-Clark Worldwide, Inc. Detection of secreted aspartyl proteases from Candida species
US20070134747A1 (en) * 2005-12-14 2007-06-14 Kimberly-Clark Worldwide, Inc. Detection of secreted lipase proteins from Candida species
CN100463675C (zh) * 2007-01-29 2009-02-25 高章圈 一种可溶性缓释外用避孕药
US20080269205A1 (en) * 2007-04-27 2008-10-30 Ondine International, Ltd. Methods to prevent vertical transmission of infectious diseases
DE102008006416A1 (de) * 2008-01-28 2009-07-30 Mayer, Thomas, Dr. med. Clindamycin zur Verwendung bei der Behandlung oder Vorbeugung der bakteriellen Vaginosis
US8591961B2 (en) * 2008-09-04 2013-11-26 Allergan, Inc. Aesthetic treatment of scars and aging skin
US8308678B2 (en) * 2008-09-23 2012-11-13 Mcneil-Ppc, Inc. Pre-filled applicator device
US8236768B2 (en) 2008-10-03 2012-08-07 3B Pharmaceuticals, Inc. Topical antiviral formulations
US9662481B2 (en) 2008-10-07 2017-05-30 Cristcot Llc Method and apparatus for inserting a rectal suppository
US8192393B2 (en) * 2008-10-07 2012-06-05 Christcot Medical Company Method and apparatus for inserting a rectal suppository
CN102985091B (zh) 2010-03-03 2016-11-23 新科蒂斯公司 使用抗微生物肽螯合化合物治疗皮肤疾病和异常的组合物和方法
EP2616061A4 (en) 2010-09-17 2014-03-12 Brassica Prot Products Llc GLUCOSINOLATE TREATMENT FORMULATIONS
BR112015008689A2 (pt) 2012-10-19 2017-07-04 Cristcot Inc método para fabricar um supositório, kit, supositório e aparelho para inserir um supositório
EP3013368A1 (en) 2013-06-25 2016-05-04 Mission Pharmacal Company Novel formulations for the treatment of vaginal disorders
US11071745B2 (en) 2014-07-07 2021-07-27 Elian Llc Viral prophylaxis treatment methods and pre-exposure prophylaxis kits
KR20170063512A (ko) * 2014-07-07 2017-06-08 프로필락시스 엘엘씨 바이러스 예방 치료 방법 및 사전-노출 예방 키트
WO2016112388A1 (en) 2015-01-10 2016-07-14 Nine Medical, Inc. Methods and devices to prevent premature birth
US11298515B2 (en) 2016-05-12 2022-04-12 Cristcot Llc Single-use suppository insertion device and method
ITUA20164065A1 (it) * 2016-06-01 2017-12-01 Probiotical Spa Composizioni in gel per applicazioni topiche a base di batteri, preparazione delle stesse e loro usi.
ES2943244T3 (es) * 2016-10-28 2023-06-12 Rb Health Us Llc Productos para la higiene femenina
CN107224663B (zh) * 2017-07-21 2019-12-03 新乡医学院第一附属医院 一种泌尿外科用尿道给药器
WO2020069013A1 (en) * 2018-09-27 2020-04-02 BioPhysics Pharma, Inc. Transdermal drug delivery system
CN110624173B (zh) * 2019-10-12 2022-02-08 南通大学附属医院 一种无创妇科护理用药装置
CN115040501B (zh) * 2022-06-06 2023-09-12 中国中医科学院广安门医院 顺-13-十八碳烯酸或其盐化合物在制备促进受损皮肤和/或黏膜愈合的药物中的应用

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US563349A (en) * 1896-07-07 Wash boiler attachment
US2683456A (en) 1953-03-02 1954-07-13 Louis A Pierson Rectal medicator
DE3324780A1 (de) * 1983-07-08 1985-01-17 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Vorrichtung zur intra-analen applikation von fluessigen oder pastoesen wirkstoffzubereitungen
DE3441609A1 (de) 1984-11-14 1986-05-22 Bramlage Gmbh, 2842 Lohne Salbenapplikator
DE3513645A1 (de) 1985-04-16 1986-10-16 Dr. Kade Pharmazeutische Fabrik GmbH, 1000 Berlin Applikator fuer haemorrhoidalsalben
FR2585575B1 (fr) * 1985-08-01 1989-03-03 Pf Medicament Compositions pharmaceutiques a activite keratolytique sous forme de gel comportant de l'acide salicylique hydro-alcoolique
US5057310A (en) * 1986-11-06 1991-10-15 Hill Ira D Method of manufacturing oral hygiene preparations containing active SnF.sub.
JPS63253026A (ja) * 1987-04-10 1988-10-20 Masahiko Ito エイズ・ウイルス増殖抑制剤
US4980152A (en) * 1987-08-06 1990-12-25 Marion Laboratories Oral preparation
JPH0624498B2 (ja) 1987-11-30 1994-04-06 ▲ひろ▼陸 佐藤 噴射装置の噴射ノズル
US5098711A (en) * 1988-11-14 1992-03-24 Ira Hill Method of treating the oral cavity with dental floss containing chemotherapeutic agents
CA2011423A1 (en) * 1989-03-07 1990-09-07 Peter M. Taylor Pharmaceutical compositions useful as drug delivery vehicles and/or as wound dressings
US5298260A (en) * 1990-05-01 1994-03-29 Mediventures, Inc. Topical drug delivery with polyoxyalkylene polymer thermoreversible gels adjustable for pH and osmolality
US5593683A (en) * 1990-05-01 1997-01-14 Mdv Technologies, Inc. Method of making thermoreversible polyoxyalkylene gels
US5185153A (en) * 1990-10-04 1993-02-09 The Research Foundation Of The State University Of New York Agents effecting the lysis of oral bacteria
WO1993000114A1 (en) * 1991-06-20 1993-01-07 Viro-Tex Corporation Topical composition enhancing healing of herpes lesions
AT408191B (de) 1991-08-19 2001-09-25 Haemosan Erzeugung Pharmazeuti Verfahren zur inaktivierung von prionen
US5260066A (en) * 1992-01-16 1993-11-09 Srchem Incorporated Cryogel bandage containing therapeutic agent
CN2171372Y (zh) * 1993-03-13 1994-07-13 谭运江 直肠液体注药器
CN1054504C (zh) * 1993-03-15 2000-07-19 科尔加特·帕尔莫利弗公司 洁牙剂
CN2183786Y (zh) * 1993-10-22 1994-11-30 盖国忠 双腔肛点器
US5424060A (en) * 1993-10-25 1995-06-13 Church & Dwight Co., Inc. Dentifrice composition containing stabilized sodium percarbonate
US6203803B1 (en) * 1994-12-14 2001-03-20 Societe L'oreal S.A. Use of a substance P antagonist in a cosmetic composition, and the composition thus obtained
ES2153485T3 (es) * 1994-07-13 2001-03-01 Alza Corp Composicion y procedimiento que incrementa la difusion percutanea por electrotransporte de una substancia.
CN1169112A (zh) * 1994-12-06 1997-12-31 普罗克特和甘保尔公司 保存稳定的，含有胶凝聚合物、脂类和脂肪酸乙二醇酯晶体的洁肤液
US5624906A (en) * 1994-12-08 1997-04-29 Lever Brothers Company, Division Of Conopco, Inc. Oral hygiene compositions comprising heteroatom containing alkyl aldonamide compounds
DE19530879A1 (de) * 1995-08-10 1997-02-13 Schuelke & Mayr Gmbh Vorrichtung zum Aufbringen von Medikamentenflüssigkeit auf Schleimhäute in Körperhöhlungen
CA2258811C (en) * 1996-05-09 2003-11-25 Michel G. Bergeron Formulation for use in the prevention of pathogen induced diseases including hiv and hsv
US6191165B1 (en) * 1996-05-31 2001-02-20 Allelix Neuroscience Inc. Pharmaceutical for treatment of neurological and neuropsychiatric disorders
US5908612A (en) * 1996-12-31 1999-06-01 Basf Corporation Oral care compositions comprising liquid polyoxyalkylene compounds as solubilizers/gelling agents
US5843043A (en) * 1997-03-25 1998-12-01 Markus; George Syringe and process for dispensing treatment fluid
US5843471A (en) * 1997-11-06 1998-12-01 Chaykin; Sterling Oral cleansing: methods and compositions
DE69819563T2 (de) * 1998-03-07 2004-09-16 Daewoong Pharmaceutical Co., Ltd., Sungnam Topische zusammensetzung enthaltend menschlichen epidermalen wachstumsfaktor
DE29807045U1 (de) * 1998-04-18 1998-06-25 Jakoubek Medizintechnik Gmbh Flexible Katheder-Hülsenführung
CN100396344C (zh) * 1998-04-21 2008-06-25 瑞克尔科感染公司 用于将液体至半固体的制剂给药至患者粘膜腔内的施用器
EP1427404A4 (en) * 2001-08-20 2005-10-26 Maiken Nedergaard TREATMENT OF GLIAL TUMORS WITH GLUTAMATE ANTAGONISTS

Also Published As

Publication number Publication date
BR9909801A (pt) 2002-01-22
US20030133969A1 (en) 2003-07-17
RU2224503C2 (ru) 2004-02-27
AU762461B2 (en) 2003-06-26
HK1037861A1 (en) 2002-02-22
DE69935325T2 (de) 2007-11-15
CN100396344C (zh) 2008-06-25
IL139173A0 (en) 2001-11-25
EP1079802A2 (en) 2001-03-07
AU3590499A (en) 1999-11-08
NZ507609A (en) 2003-09-26
TR200003074T2 (tr) 2001-01-22
KR20010042875A (ko) 2001-05-25
DE69935325D1 (de) 2007-04-12
NO20005310D0 (no) 2000-10-20
CN1597008A (zh) 2005-03-23
ATE355050T1 (de) 2006-03-15
CN100374110C (zh) 2008-03-12
ES2284250T3 (es) 2007-11-01
JP4665075B2 (ja) 2011-04-06
TR200102067T2 (tr) 2002-06-21
EP1769821A1 (en) 2007-04-04
ID26791A (id) 2001-02-08
JP2002512180A (ja) 2002-04-23
AR018194A1 (es) 2001-10-31
NO20005310L (no) 2000-12-21
US7192607B2 (en) 2007-03-20
EP1079802B1 (en) 2007-02-28
WO1999053897A2 (en) 1999-10-28
PL344111A1 (en) 2001-10-08
WO1999053897A3 (en) 2000-04-13
SK15822000A3 (sk) 2001-08-06
CN1302215A (zh) 2001-07-04
HUP0101507A2 (hu) 2002-03-28
US6500460B1 (en) 2002-12-31

Similar Documents

Publication Publication Date Title
HUP0101507A3 (en) Formulation for the prevention or the treatment of diseases affecting mucosae or skin, or for pregnancy prevention, and an applicator for the delivery of topical formulation into mucosal cavities
HK1034189A1 (en) An acidified composition for topical treatment of nail and skin conditions.
AU1063201A (en) Use of tgf beta and growth factors in the treatment and prevention of diseases of the intestinal mucosa
HUP0104424A3 (en) Improved formulation for topical non-invasive application in vivo
PT1304992E (pt) Sistema de distribuição em gel cutâneo para tratamento de desordens da pele
AU6549898A (en) Method for the broad based treatment of infections, especially infections of organs such as the skin and vagina
IL127943A0 (en) Pharmaceutical and cosmetic composition for the treatment of skin disorders
AU2313499A (en) Bioactive glass treatment of inflammation in skin conditions
AU7067200A (en) Skin care compositions and treatments
AU1773600A (en) Topical treatment of skin disease
HUP0102781A3 (en) Vitamin e and esters thereof for use in the topical treatment of mucosal pathologies
HK1022269A1 (en) Use of 1-hydroxy-2-pyridones in the manufacture of a medicament for treating skin infections
AU4262599A (en) Preparation for treating human skin and human hair comprising a special active ingredient combination, and the use of this active ingredient combination
AU3593599A (en) Drugs for reducing vaginal acidity and treatment of vaginitis, and the use thereof
GB9929497D0 (en) Improved amino acid mixtures for the treatment and/or management of certain diseases
HUP0000785A3 (en) Ointment for the treatment of burns and other skin diseases
AU5076601A (en) Pulmonary delivery of ribavirin or levovirinTM for systemic and quasi-systemic treatment of disease
AU3061199A (en) Skin treatment compositions and the use thereof
AU4035399A (en) Therapeutic system for applying at least one care or active agent topically or transmucosally, on or through the nasal mucosa, and method for using the system
IL136342A0 (en) Formulation for topical treatment of skin infections
ZA97253B (en) Topical compositions for the treatment of skin diseases
AU2002365939A1 (en) Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
AU3887399A (en) Hair and skin treatment method and composition
AU2002313992A1 (en) Compositions and Methods for Treatment of Mitochondrial Diseases
AU5523298A (en) Novel topical formulation of anti-inflammatory drugs for the treatment of localized pain

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees